Detalhe da pesquisa
1.
Change of voltage-gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model.
Eur J Neurosci
; 59(12): 3292-3308, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650308
2.
Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis.
Proc Natl Acad Sci U S A
; 118(13)2021 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753489
3.
Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy.
FASEB J
; 33(7): 8110-8124, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30933664
4.
Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management.
Eur Heart J
; 38(27): 2132-2136, 2017 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011703
5.
Continuous infusion of manganese improves contrast and reduces side effects in manganese-enhanced magnetic resonance imaging studies.
Neuroimage
; 147: 1-9, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27777173
6.
Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
Eur J Neurosci
; 43(12): 1623-35, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27037492
7.
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.
Proc Natl Acad Sci U S A
; 110(51): 20783-8, 2013 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24297891
8.
The pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathies.
J Anat
; 224(1): 36-44, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23937354
9.
Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Brain
; 135(Pt 4): 1081-101, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22396395
10.
Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK.
Sci Rep
; 13(1): 7478, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156800
11.
A bioassay for neuromuscular junction-restricted complement activation by myasthenia gravis acetylcholine receptor antibodies.
J Neurosci Methods
; 373: 109551, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247492
12.
Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders.
Lancet Neurol
; 21(2): 163-175, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065039
13.
High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice.
Ann Neurol
; 67(1): 85-98, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20186955
14.
Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy.
J Neuromuscul Dis
; 8(5): 845-863, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33044191
15.
Severe and progressive neurotransmitter release aberrations in familial hemiplegic migraine type 1 Cacna1a S218L knock-in mice.
J Neurophysiol
; 104(3): 1445-55, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20631222
16.
Total ganglioside ablation at mouse motor nerve terminals alters neurotransmitter release level.
Synapse
; 64(4): 335-8, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19957367
17.
Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.
Muscle Nerve
; 42(2): 283-8, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20544919
18.
Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.
J Physiol
; 587(Pt 16): 3979-99, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19564393
19.
The ataxic Cacna1a-mutant mouse rolling nagoya: an overview of neuromorphological and electrophysiological findings.
Cerebellum
; 8(3): 222-30, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19484318
20.
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.
Brain
; 131(Pt 5): 1197-208, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18184663